Skip to main content
TipRanks
Go Ultimate75% OFF

Tango Therapeutics, Inc. Insider Profile

4 Followers

Tango Therapeutics, Inc., former Director at Blueprint Medicines, holds 3.40K shares in Blueprint Medicines (Ticker: BPMC).

Tango Therapeutics, Inc.'s Trading History

BPMC
Blueprint Medicines
Dec 10, 2021―Uninformative Buy―$440.16K
BPMC

Tango Therapeutics, Inc. has not reported any informative transactions for BPMC, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 10, 2021Uninformative Buy$0.003,400$0.00―

You May Also Like

Tango Therapeutics, Inc. insider profile FAQ

What stocks does Tango Therapeutics, Inc. hold?
Tango Therapeutics, Inc. holds: BPMC stocks.
What is Tango Therapeutics, Inc.'s role in Blueprint Medicines?
Tango Therapeutics, Inc.'s role in Blueprint Medicines is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.